{"id":"https://openalex.org/W3028947754","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21664","title":"Hyperprogressive disease during treatment with immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC).","display_name":"Hyperprogressive disease during treatment with immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC).","publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3028947754","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21664","mag":"3028947754"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.e21664","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21664","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21664","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Pablo Ayala de Miguel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pablo Ayala de Miguel","raw_affiliation_strings":["Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, Caceres, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, Caceres, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053105460","display_name":"Javier L\u00f3pez Gallego","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier L\u00f3pez Gallego","raw_affiliation_strings":["Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112620778","display_name":"Itziar Gorospe Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Itziar Gorospe Garc\u00eda","raw_affiliation_strings":["Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027867948","display_name":"Pablo Ren\u00e9 Rivera Vargas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pablo Ren\u00e9 Rivera Vargas","raw_affiliation_strings":["Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074741269","display_name":"Andrea Posada Restrepo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Andrea Posada Restrepo","raw_affiliation_strings":["Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012634512","display_name":"Jonathan Aires Machado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jonathan Aires Machado","raw_affiliation_strings":["Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043082781","display_name":"Rub\u00e9n Alonso Calder\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rub\u00e9n Alonso Calder\u00f3n","raw_affiliation_strings":["Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jos\u00e9 Manuel Rodr\u00edguez Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Manuel Rodr\u00edguez Garc\u00eda","raw_affiliation_strings":["Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eduardo Ceballos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eduardo Ceballos","raw_affiliation_strings":["Hospital San Pedro Alcantara, Caceres, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital San Pedro Alcantara, Caceres, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074885015","display_name":"Alfonso Acero Caballero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alfonso Acero Caballero","raw_affiliation_strings":["Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, SD, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, SD, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043385482","display_name":"Andrea Ill\u00e1n Varella","orcid":"https://orcid.org/0000-0002-1833-7109","observed_orcids":["https://orcid.org/0000-0002-1833-7109"]},"institutions":[{"id":"https://openalex.org/I4210161885","display_name":"Hospital Virgen del Puerto","ror":"https://ror.org/05peke140","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210161885"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Andrea Ill\u00e1n Varella","raw_affiliation_strings":["Department of Clinical Oncology, Virgen del Puerto Hospital, Plasencia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Virgen del Puerto Hospital, Plasencia, Spain;","institution_ids":["https://openalex.org/I4210161885"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038929371","display_name":"Laura Quintana Cort\u00e9s","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Quintana Cort\u00e9s","raw_affiliation_strings":["Department of Clinical Oncology, Hospital of M\u00e9rida, M\u00e9rida, Spain., M\u00e9rida, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Hospital of M\u00e9rida, M\u00e9rida, Spain., M\u00e9rida, Spain;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113937544","display_name":"Pablo Borrega Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111317","display_name":"Hospital San Pedro de Alc\u00e1ntara","ror":"https://ror.org/01yp8kc21","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111317"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pablo Borrega Garcia","raw_affiliation_strings":["Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, Caceres, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, University Hospital San Pedro de Alc\u00e1ntara, Caceres, Spain;","institution_ids":["https://openalex.org/I4210111317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"e21664","last_page":"e21664"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperprogressive-disease","display_name":"hyperprogressive disease","score":0.9909999966621399},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9850000143051147},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9610000252723694},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8399999737739563},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.828000009059906},{"id":"https://openalex.org/keywords/tumor-growth-rate","display_name":"tumor growth rate","score":0.6949999928474426},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8899999856948853},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.35600000619888306},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.5080000162124634},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.4790000021457672},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.47999998927116394},{"id":"https://openalex.org/keywords/smoking-status","display_name":"smoking status","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.95032799243927},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6534826755523682},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.651419997215271},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5958775281906128},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5242441296577454},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4873989224433899},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.4831482768058777},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.47763338685035706},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4648396670818329},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45218437910079956},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.42031678557395935},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.e21664","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21664","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21664","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2995514617","https://openalex.org/W4281783537","https://openalex.org/W3045574498","https://openalex.org/W2949640269","https://openalex.org/W2982486584","https://openalex.org/W3028743954","https://openalex.org/W3048614517","https://openalex.org/W2891190273","https://openalex.org/W2891266481","https://openalex.org/W3033353648"],"abstract_inverted_index":{"e21664":[0],"Background:":[1],"Hyperprogressive":[2],"disease":[3,138],"(HPD)":[4],"is":[5,14,354],"a":[6,113,129,374],"new":[7],"pattern":[8],"of":[9,19,31,48,61,67,71,122,161,169,182,195,212,220,222,240,259,266,273,293,324,335,349,377],"progressi\u00f3n":[10],"during":[11,22,282],"immunotherapy":[12],"and":[13,74,86,94,107,125,164,172,189,202,228,254,299,385],"described":[15,135,364],"as":[16,91,137],"an":[17,144],"acceleration":[18],"tumor":[20,147],"growth":[21,148],"treatment":[23,283,294,382],"with":[24,76,143,174,284,302,356,373,383,387,392],"immune":[25],"checkpoint":[26],"inhibitors":[27],"(ICI).":[28],"The":[29,101,322,347],"rate":[30,149],"HPD":[32,136,281,286,336,350,369],"in":[33,44,50,78,98,146,236,277,295,306,337,351,390],"advanced":[34,72,393],"solid":[35],"tumors":[36],"remains":[37],"unknown,":[38],"but":[39],"it":[40],"has":[41],"been":[42],"reported":[43],"9%":[45],"to":[46,57,118,153,263,332],"29%":[47],"patients":[49,69,196,213,232,241,260,275,391],"two":[51,291],"recent":[52],"series.":[53],"Our":[54],"aim":[55],"was":[56,300,330,370],"study":[58],"prognostic":[59],"factors":[60],"HPD.":[62],"Methods:":[63],"We":[64,134],"collected":[65],"data":[66],"104":[68,274],"diagnosed":[70],"NSCLC":[73],"treated":[75],"ICI":[77,384],"monotherapy":[79],"at":[80,140,217],"our":[81,278,352],"institution":[82],"between":[83],"December":[84,87],"2015":[85],"2019.":[88],"Several":[89],"variables":[90,102],"clinical,":[92],"tumour-related":[93],"therapeutical":[95],"were":[96,103,185,270],"included":[97],"the":[99,120,123,218,289,307,333,338],"analysis.":[100,133],"compared":[104],"by":[105,310,365],"chi-square":[106],"Fisher":[108],"test,":[109],"then":[110],"we":[111,127],"performed":[112,128],"multivariate":[114,308,339],"logistic":[115],"regression":[116,312],"model":[117],"analyse":[119],"effects":[121],"covariates,":[124],"finally":[126],"Kaplan":[130],"Meier":[131],"survival":[132,305],"progression":[139],"first":[141,290],"evaluation":[142],"increase":[145],"exceeding":[150],"50%,":[151],"according":[152],"Gustave":[154],"Roussy":[155],"criteria":[156],"previously":[157,363],"reported.":[158],"Results:":[159],"Cohort":[160],"84":[162],"men":[163],"20":[165],"women,":[166],"median":[167],"age":[168],"67":[170],"years":[171],"86%":[173],"Eastern":[175],"Cooperative":[176],"Oncology":[177],"Group":[178],"(ECOG)":[179],"Performance":[180],"Status":[181],"0-1.":[183],"89%":[184],"active":[186],"or":[187,326],"ex-smokers":[188],"11%":[190],"had":[191,197,204,214,233,242,247,261],"never":[192],"smoked.":[193],"60%":[194],"adenocarcinoma":[198],"histology,":[199],"39%":[200],"scamous":[201],"1%":[203],"not":[205],"otherwise":[206],"specified":[207],"(NOS)":[208],"carcinoma":[209],"histology.":[210],"3%":[211],"III-B":[215],"stage":[216],"moment":[219],"start":[221,381],"immunotherapy,":[223],"37%":[224],"M1a,":[225],"30%":[226,229],"M1b":[227],"M1c.":[230],"2":[231,325],"driver":[234],"mutations":[235],"EGFR":[237],"gene.":[238],"41%":[239],"unknown":[243],"PDL1":[244,249],"status;":[245],"14%":[246,251],"no":[248],"expression,":[250],"low":[252],"expression":[253],"31%":[255],"high":[256,375],"expression.":[257],"78%":[258],"progressed":[262],"prior":[264],"line":[265],"treatment,":[267],"while":[268],"22%":[269],"treatment-naive.":[271],"Nine":[272],"(8.7%)":[276],"population":[279,353],"developed":[280],"ICI.":[285],"occured":[287],"within":[288],"months":[292],"all":[296],"9":[297],"patients,":[298],"associated":[301,372],"worse":[303],"overall":[304],"analysis":[309,340],"Cox":[311],"(12.6":[313],"vs":[314],"2.6":[315],"months;":[316],"HR":[317],"13.94,":[318],"p":[319,343],"<":[320],"0.001).":[321],"presence":[323],"more":[327],"metastatic":[328,378],"sites":[329,379],"related":[331],"development":[334],"(HR":[341],"8.59,":[342],"=":[344],"0.026).":[345],"Conclusions:":[346],"incidence":[348],"concordant":[355],"previous":[357],"report":[358],"about":[359],"this":[360],"topic.":[361],"As":[362],"Ferrara":[366],"et":[367],"al,":[368],"significantly":[371],"number":[376],"before":[380],"correlated":[386],"poor":[388],"outcomes":[389],"NSCLC.":[394]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2020-06-05T00:00:00"}